Trinity Capital Inc. Stock Price, News & Analysis

Trinity Capital (TRIN) reported strong Q1 2025 financial results with total investment income growing 29.5% year-over-year to $65.4 million. The company achieved net investment income of $32.4 million ($0.52 per share) and a net asset value of $833.4 million ($13.05 per share). During the quarter, Trinity made total gross investments of $220.4 million, including $94.8 million in six new portfolio companies and $125.6 million in existing ones. The company maintained strong portfolio quality with only 0.9% of debt investments on non-accrual status. Trinity's debt portfolio consists of 77.9% first-lien loans and achieved a 15.3% effective yield. The company declared its 21st consecutive regular dividend of $0.51 per share and ended the quarter with $216.4 million in available liquidity.

Trinity Capital (NASDAQ: TRIN) has received a new investment grade long-term issuer rating of Baa3 with a stable outlook from Moody's Investors Services. The rating agency highlighted Trinity's investment expertise, growing performance record, low reliance on secured funding, and strong capitalization and liquidity as key factors. Moody's also acknowledged Trinity's expanded scale and diversification through new business verticals in life sciences, sponsor finance, and asset-based lending, complementing its core technology lending and equipment finance operations.

According to CFO Michael Testa, this rating validation is expected to enable Trinity to access capital at more favorable rates and from a broader investor base.

Trinity Capital Inc. (Nasdaq: TRIN) has reported significant investment activity for Q1 2025, with $220 million in total investments funded. The funding breakdown includes:

• $148 million in secured loans
• $71 million in equipment financings
• $1 million in warrant and equity investments

The company originated $186 million in new commitments, distributing $95 million to six new portfolio companies and $125 million to 19 existing portfolio companies. Portfolio repayments and exits totaled $157 million, comprising $78 million from scheduled debt payments, $44 million from early repayments, and $35 million from sold investments. Complete Q1 2025 financial results will be released on May 7, 2025.

Trinity Capital Inc. (TRIN) has scheduled its first quarter 2025 financial results announcement for May 7, 2025 at 8:00 a.m. ET. The company will host a conference call at 12:00 p.m. ET on the same day to discuss the results.

Investors can access the call by dialing (800) 267-6316 domestically or (203) 518-9783 internationally, using Conference ID: TRINQ125. A taped replay will be available until May 14, 2025, accessible at (800) 839-4197 or (402) 220-2987. Additionally, a live webcast will be available on the company's Investor Relations website, with the replay remaining accessible for 90 days following the call.

Trinity Capital Inc. (NASDAQ: TRIN) has committed up to $68.75 million in growth capital to CMR Surgical, as part of the company's recent $200+ million financing round. CMR Surgical, based in Cambridge, UK, develops the Versius Surgical Robotic System, a soft-tissue surgical robot recently granted FDA marketing authorization for Cholecystectomy procedures in the United States.

The funding will support CMR Surgical's operational scaling and commercial expansion globally, with a particular focus on the U.S. market launch. The company aims to make robotic minimal access surgery more accessible and affordable for hospitals and surgical teams worldwide.

Trinity Capital (Nasdaq: TRIN) has declared a quarterly cash dividend of $0.51 per share for Q1 2025, maintaining the same level as Q4 2024. This marks the company's 21st consecutive quarter of consistent or increased dividend payments to shareholders.

The company aims to distribute quarterly dividends totaling 90% to 100% of its taxable quarterly income to maintain its regulated investment company tax status. Trinity may also pay supplemental dividends to distribute approximately all annual taxable income in the year earned, or carry over excess taxable income for future dividend payments.

Trinity Capital (NASDAQ: TRIN) has appointed Zach Taffet as Director of Capital Formation & Investor Relations to strengthen its institutional fundraising initiatives. Taffet, who previously served on BlackRock's Infrastructure Capital Formation Team, brings nearly a decade of experience in capital raising and investor relations.

During his tenure at BlackRock, Taffet was instrumental in securing $13 billion in institutional capital commitments across multiple funds and played a important role in launching the franchise's fifth vintage fund. In his new role at Trinity, he will help drive the strategic direction for the company's private fund strategies and manage institutional capital through its RIA platform.

Trinity Capital Inc. (NASDAQ: TRIN) has announced the appointment of John Orlando as Managing Director of Life Sciences, based in Boston, expanding its presence to the East Coast. Orlando, who brings over a decade of venture lending experience, joins from Flagship Pioneering where he led debt advisory functions. Prior to this, he provided debt and banking services at J.P. Morgan and Pacific Western Bank.

The appointment strengthens Trinity's Life Sciences division, with Orlando reporting to Rob Lake, Senior Managing Director of Life Sciences. The move signals Trinity's strategic expansion in the Northeast region, leveraging Orlando's industry relationships and expertise in venture lending.

Trinity Capital (TRIN) reported strong Q4 and full-year 2024 results, marking significant growth across key metrics. Q4 highlights include total investment income of $70.8 million (up 48.1% YoY), record net investment income of $34.6 million ($0.58 per share), and a 17.4% Return on Average Equity.

The company achieved total gross investments of $297.3 million in Q4, including $233.4 million in 9 new portfolio companies. Full-year 2024 performance showed total investment income of $237.7 million (30.7% YoY increase) and net investment income of $115.8 million ($2.20 per share). Platform assets under management grew 40.6% to $2.0 billion.

The investment portfolio's fair value reached $1.73 billion, comprising 76.5% first-lien loans. The company maintained strong liquidity with $496.6 million available and expanded its KeyBank Credit Facility to $600 million.